RYR2
RYR2 (ryanodine receptor 2) is a cytosolic calcium-activated calcium channel of the sarcoplasmic reticulum membrane that releases Ca(2+) into the cytosol to trigger cardiac muscle contraction. It was formerly known as ARVC2, VTSIP and ARVD2. Browse Assay Genie's current range of RYR2 research reagents below, or read on for the biology behind the target.
RYR2 is a cytosolic calcium-activated calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytosol, and so plays a key role in triggering cardiac muscle contraction. In cardiac myocytes, release is triggered by a rise in cytosolic Ca(2+) following activation of the L-type calcium channel CACNA1C. Channel activity is modulated by the formation of heterotetramers with RYR3. The protein is required for cellular calcium ion homeostasis and for embryonic heart development, and aberrant channel activation can lead to cardiac arrhythmia.
The RYR2 gene encodes the ryanodine receptor found in cardiac muscle sarcoplasmic reticulum. According to the NCBI Gene summary, the functional calcium channel is composed of a tetramer of ryanodine receptor proteins together with a tetramer of FK506 binding protein 1B proteins, and it supplies calcium to cardiac muscle. The protein belongs to the ryanodine receptor family (TC 1.A.3.1), RYR2 subfamily, and is closely related to RYR1. HGNC places the gene in the groups for ryanodine receptors, EF-hand domain containing and armadillo like helical domain containing proteins, and also lists it among microRNA protein coding host genes. Mouse and rat both carry a Ryr2 ortholog.
Mutations in the RYR2 gene are associated with stress-induced polymorphic ventricular tachycardia and arrhythmogenic right ventricular dysplasia. This disease link explains the earlier names and symbols still found in the literature, including arrhythmogenic right ventricular dysplasia 2 (ARVD2, ARVC2) and VTSIP. The earlier descriptive name ryanodine receptor 2 (cardiac) reflects its main site of action in the heart.
RYR2 releases sarcoplasmic reticulum Ca(2+) after L-type channel activation, making it central to how cardiac muscle contraction is triggered.
Aberrant RYR2 channel activation can lead to arrhythmia, and mutations are linked to stress-induced polymorphic ventricular tachycardia.
RYR2 is required for cellular calcium ion homeostasis, making it a key component in studies of intracellular Ca(2+) handling.
RYR2 is required for embryonic heart development, linking calcium-release channel function to the formation of the heart.
RYR2 is a calcium-activated calcium channel in the sarcoplasmic reticulum membrane. It releases Ca(2+) into the cytosol of cardiac myocytes after activation of the L-type calcium channel CACNA1C, triggering contraction. It also supports calcium ion homeostasis and embryonic heart development.
RYR2 stands for ryanodine receptor 2, also written ryanodine receptor 2 (cardiac). Earlier symbols include ARVC2, ARVD2 and VTSIP, with the former name arrhythmogenic right ventricular dysplasia 2. These reflect the disease associations of the gene.
Mutations in the RYR2 gene are associated with stress-induced polymorphic ventricular tachycardia and arrhythmogenic right ventricular dysplasia. Mouse and rat each have a Ryr2 ortholog; check the datasheet of any product for its validated reactivity.
Other ryanodine receptors and calcium-signalling partners of RYR2 with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q92736; product specifications from Assay Genie datasheets.